Carcinoma in Situ Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol
In this study, the effect of a subcutaneous spacer injection on the skin dose, late skin toxicity, and cosmetic outcome is tested in patients treated with PBSI in the setting of breast-conserving therapy. Our results will be relevant for most forms of breast brachytherapy as well as robotic radiosurgery, as skin spacers could protect the skin with these other techniques.Trial registrationNetherlands Trial Register,NTR6549. Registered on 27 June 2017. (Source: Trials)
Source: Trials - December 17, 2018 Category: Research Source Type: clinical trials

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer
Condition: Outcome of Breast Cancer Intervention: Other: None intervention Sponsor: Omphis Foundation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2018 Category: Research Source Type: clinical trials

Estudy of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer
Condition: Outcome of Breast Cancer Intervention: Other: None intervention Sponsor: Omphis Foundation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2018 Category: Research Source Type: clinical trials

MRI in Ductal Carcinoma in Situ (DCIS)
Condition: Ductal Carcinomas Intervention: Sponsor: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2018 Category: Research Source Type: clinical trials